MCH ANALYSIS EQUITY RESEARCH
General research — not personal financial advice ← Library
BRO HOLD REF $62.88 PW TARGET $61.71 (-2% vs spot · 12m PWEV) -2% Single-name research · 12 October 2026
Equity ResearchFinancials · Insurance Brokers
BRO

Brown & Brown Inc (BRO)

HOLD. 12-month probability-weighted target $62 (-2% vs spot). P/E Multiple explains 72% of Monte Carlo outcome variance.

HOLD RESEARCH mature cash generator 12 October 2026
$62.88 → $61.71 (-2% vs spot · 12m PWEV) -2% 12-month probability-weighted
Expected return (1y)-1.9%
Fair value vs price-10.0%
Quality72/100
Bull / bear scenario ratio1.2×
Downside probability62%
Expected alpha (1y)-5.5%
Forward P/E14.0x
DCF (exit-multiple terminal)$48.46 · terminal 70% of EV
Valuation confidencemedium
Key metric to watchTotal revenue growth, year-on-year (as reported)
The case. narrow moat, mature cash generator
The problem. house in-line consensus; Total revenue growth, year-on-year (as reported)
What changes our mind. Total revenue growth, year-on-year (as reported) < 0.035

Model history: across 478 scored pre-registered anchors (of 480), the direction implied by our targets has been right 55.2% of the time, above the 50% a coin flip would give. Treat the expected return as a distribution estimate, not a point forecast. This name's record ↓ · full record.

General research — not personal financial advice · full disclosures in Part 9 below · How to read this card

Contents
FORECAST — estimate, not a result. Performance policy
01Investment Decision

Investment Committee Summary

Rating HOLD
Internal 5-tier HOLD
Classification · conviction mature cash generator · medium
Evidence 8/8 load-bearing inputs sourced
Triangulated fair value $56.59 (-10% vs spot · triangulated FV)
12-mo scenario PWEV $61.71 (-2% vs spot · 12m PWEV)
Next catalyst 2026-10-26 — Quarterly earnings
Primary thesis-break Total revenue growth, year-on-year (as reported) < 0.035 (2 consecutive prints)
Decision detail — rating tables & Research OS strip

Rating: HOLD

Internal 5-tier: HOLD · mature cash generator · analyst conviction: medium

Metric Value
Current Price $62.88
Triangulated Fair Value $56.59 (-10% vs spot · triangulated FV)
12-mo Scenario PWEV $61.71 (-2% vs spot · 12m PWEV)
Forward P/E 14.0x
Market Cap $20B
52-Week Range $53.81–$96.13 (intraday high and low over the trailing 52 weeks of the stock's own daily bars)

EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).


Methodology: Valuation triangulated across four weighted anchors — an intrinsic DCF, a scenario-weighted PWEV, a Monte Carlo median (Student-t + regime switching) and a peer P/E re-rate. Anchors are blended at fixed declared weights, each counted separately; the Monte Carlo, the scenario PWEV and the DCF's exit-multiple terminal all rest on the same base multiple, so where they agree it is partly by construction — not independent corroboration. Figures reconciled to Alpha Vantage 2026-10-09. Each chart below sits with the part of the thesis it evidences.

General research, published identically to every reader. Not personal financial advice. Figures as of the analysis date; verify before acting.

Decision Support — Research OS jump to detail ↓

Research conviction Exp. return (1y) Rules stance Next catalyst
55.3/100 (39th pct) -0% 1yr expected Hold 14d — Quarterly earnings

Full breakdown — conviction components, probability-return distribution, decision rules, factor & portfolio interaction and the catalyst timeline — in the Decision Support sections below. Model output for research; not personal financial advice.

📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.

Recommendation: HOLD

Balanced: triangulated fair value $56.59 (-10% vs spot); the outcome hinges on P/E Multiple. The debate is P/E Multiple — fundamentally a multiple/regime call.

02Thesis, Anti-Thesis & Variant View

Investment Thesis

At $62.88 (12 October 2026) Brown & Brown trades on 14x forward earnings against a higher insurance-broker peer median, and well below its 52-week high. The market is pricing a roll-up that levered up near the top of the commercial property and casualty pricing cycle, just as that cycle softens. The engine partly agrees. Probability-weighting the tree gives $61.71, and the triangulated fair value lands at $56.59, or -10% against the current price, leaving the shares fairly valued against that estimate; the capex-bridge discounted cash flow and the simulated median read lower again, and most of the simulated variance is carried by the multiple rather than by the business drivers. The Gordon terminal and the peer cross-read argue the discount is overdone, but they do not carry the blend. HOLD follows.

Narrative drafted 2026-08-16 by claude-opus-5 under supervision; reviewed by Marinus 2026-08-16.

The dashboard below is the whole argument on one page: spot ($62.88) against each valuation anchor, the scenario tree, technicals and the options-implied move.

Integrated dashboard. The four weighted valuation anchors bracket the $62.88 spot from $48.46 to $72.10 — stretched — spot sits above the skeptical blend.
Integrated dashboard. The four weighted valuation anchors bracket the $62.88 spot from $48.46 to $72.10 — stretched — spot sits above the skeptical blend.

Anti-Thesis (The Real Bear Case)

The steelman bear is mechanical, not sentimental. Commercial property and casualty pricing has compounded for years; when the cycle turns, broker commissions fall with premium rates while expense bases built for a hard market do not. The structural scenario's target, below the 52-week low, is the honest price of that combination — and it is the heaviest weight on the downside of the tree, not a stress-test flourish.

Key Debate

P/E Multiple explains 72% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.

What the Market Is Pricing In

At the current price, the market pays 14.0× consensus forward EPS, vs the house DCF terminal 12.0×, and a peer median 16.1×. The house DCF sits 23% below spot, so the market is pricing in more than the house case — roughly 1.9pp of revenue CAGR.

Variant perception: the house view is below-consensus, and the thesis is primarily FCF-driven.

Metric Consensus House Importance
Revenue 7.0 6.7 High
EPS 4.5 4.5 Medium
Target price 75.1 61.8 Medium
03Scenario & Valuation

Scenario Analysis

The scenario tree spans a structural 'Structural — Soft-Market / Commission Pressure' downside ($32.30) to a 'Bull — Defensive Re-Rate' bull case ($98.40); the probability-weighted blend (PWEV $61.71) is -2% versus spot.

Scenario Probability Target Return vs spot
Structural — Soft-Market / Commission Pressure 20% $32.30 -49%
Economic / Exposure Recession 17% $52.00 -17%
Base — Organic + Pricing + M&A 35% $64.70 +3%
Growth — Specialty / International / Consolidation 20% $84.10 +34%
Bull — Defensive Re-Rate 8% $98.40 +56%
Probability-Weighted (PWEV, after SBC dilution) — $61.71 -2%

SBC charge: scenario targets are gross per-share prices; the PWEV is reduced by one year of stock-based-compensation dilution (1.5% of shares, on SBC ≈ 2% of revenue), trimming the gross PWEV of $62.64 to $61.71 (-1.5%). SBC is charged once, as dilution — never also deducted from FCF.

Scenario rationale — the driver path behind every target:

  • Structural — Soft-Market / Commission Pressure (20%, $32.30). Structural impairment — soft-market / commission pressure: earnings AND the multiple compress together. Target sits below the 52-week low by construction.
  • Economic / Exposure Recession (17%, $52.00). Cyclical downturn — brokerage organic growth + P&C pricing cycle + bolt-on M&A (fee/commission, no underwriting risk) weakens for 1–2 years before normalising.
  • Base — Organic + Pricing + M&A (35%, $64.70). Mid-cycle — normalised brokerage organic growth + P&C pricing cycle + bolt-on M&A (fee/commission, no underwriting risk); disciplined capital allocation; steady returns.
  • Growth — Specialty / International / Consolidation (20%, $84.10). Upside — specialty / international / consolidation lifts earnings above mid-cycle; the multiple expands modestly.
  • Bull — Defensive Re-Rate (8%, $98.40). Upside tail — sustained tight conditions or a structural re-rate on specialty / international / consolidation.
Five-scenario tree. Probability-weighted targets around the $62.88 spot; PWEV $61.71 (-2% vs spot · 12m). the payoff shows modest negative expectancy — downside mass dominates (range $32.30–$98.40)
Five-scenario tree. Probability-weighted targets around the $62.88 spot; PWEV $61.71 (-2% vs spot · 12m). the payoff shows modest negative expectancy — downside mass dominates (range $32.30–$98.40)

Valuation Triangulation

Four weighted anchors — an intrinsic dcf, a scenario-weighted pwev, a monte carlo median (student-t + regime switching) and a peer p/e re-rate — read them with their basis in mind. The Monte Carlo, the scenario PWEV, any DCF's exit-multiple terminal and any peer re-rate key off a market multiple, so they are not independent; only a DCF's explicit-period cash flows are multiple-free, and its terminal usually carries most of its value. The discipline is to read the spread, not to treat four numbers as four independent votes.

Method Basis Fair Value vs Spot Weight in this name's blend
Monte Carlo median (Student-t + regime) multiple $56.67 -10% 18% (declared 15%)
Peer P/E re-rate multiple $72.10 +15% 12% (declared 10%)
Peer EV/Revenue re-rate multiple $57.97 -8% 0% — cross-check only
Scenario PWEV multiple $61.71 -2% 29% (declared 25%)
DCF (5-year + exit-multiple terminal) cash flow + terminal × $48.46 -23% 41% (declared 35%)
Triangulated (weighted) — $56.59 -10% 100%

The house blend DECLARES five anchor weights — DCF 35%, scenario PWEV 25%, Monte Carlo 15%, sum-of-parts 15%, peer re-rate 10%. For this name sum-of-parts is not computed, so 15% of the declared weight is redistributed across the anchors that exist — which is why the weights above differ from the declared ones. The fair value is unaffected by this disclosure; the blend has always worked this way. The company-lever row in the Sensitivity section is an illustrative EBIT × multiple value, not a sum-of-parts anchor.

Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.

Monte Carlo — the outcome distribution

10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $56.67 and 38% of paths finish above spot. The variance decomposition shows the p/e multiple is the dominant swing factor (72% of variance). Value is a multiple bet: fundamentals move the answer far less than the rating does.

Monte Carlo distribution. Median $56.67; P(price > current) 38%. P10–P90: $35.05–$84.79.
Monte Carlo distribution. Median $56.67; P(price > current) 38%. P10–P90: $35.05–$84.79.

DCF — explicit-period cash flows with an exit-multiple terminal

A 5-year cash-flow path discounted at a WACC of 8.0%, plus a terminal value of final-year FCF × 12.0x — a terminal multiple equal to 0.85 × the base multiple that the Monte Carlo and the scenario tree also use → $48.46. The terminal value is 70% of enterprise value, so this anchor moves with the multiple assumption. The heaviest anchor in this blend (41%); because its terminal is a market multiple, it is not independent of the multiple-driven anchors.

DCF (exit-multiple terminal). WACC 8.0%, 12.0x terminal → $48.46; terminal 70% of EV.
DCF (exit-multiple terminal). WACC 8.0%, 12.0x terminal → $48.46; terminal 70% of EV.

Peer benchmarking — relative value

Against its 4 peers in the same GICS sub-industry, re-rating to their median forward multiple (P/E 16.1x) implies $72.10. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so market sentiment does not set the fair value.

Cross-sectional peer benchmarking. Same-sub-industry median fwd P/E 16.1x → $72.10; EV/Rev re-rate → $57.97.
Cross-sectional peer benchmarking. Same-sub-industry median fwd P/E 16.1x → $72.10; EV/Rev re-rate → $57.97.

Across all anchors the spread is 41% of the median — wide (genuine disagreement — the blend carries low valuation confidence).

Sensitivity

DCF/share — WACC × terminal multiple

WACC \ Term× 8.4x 10.2x 12.0x 13.8x 15.6x
6.0% $38.31 $46.40 $54.49 $62.58 $70.66
7.0% $35.96 $43.67 $51.39 $59.11 $66.83
8.0% $33.72 $41.09 $48.46 $55.82 $63.19
9.0% $31.60 $38.64 $45.67 $52.71 $59.74
10.0% $29.59 $36.31 $43.03 $49.75 $56.47

DCF/share — revenue CAGR Δ × model op-margin Δ (Δ applied to the DCF's house margin path)

CAGRΔ \ MgnΔ -3.0pp -1.5pp +0.0pp +1.5pp +3.0pp
-3.0pp $33.95 $37.03 $40.10 $43.18 $46.26
-1.5pp $37.62 $40.89 $44.17 $47.44 $50.72
+0.0pp $41.48 $44.97 $48.46 $51.94 $55.43
+1.5pp $45.56 $49.27 $52.98 $56.68 $60.39
+3.0pp $49.86 $53.80 $57.74 $61.68 $65.62

Tornado — DCF/share swing by driver (widest first)

Driver Low High Swing
Revenue CAGR ±3pp $40.00 $58.00 $18.00
Terminal × ±15% $41.00 $56.00 $15.00
Model op margin ±3pp $41.00 $55.00 $14.00
WACC ±1pp $46.00 $51.00 $6.00
Capex intensity ±15% $48.00 $49.00 $1.00

Company lever — value at the base multiple vs Insurance Brokerage multiple (base 13.0x)

Multiple 9.1x 11.0x 13.0x 14.9x 16.9x
Value at the base multiple (EBIT × multiple; illustrative, not a blend anchor) $32.00 $43.00 $55.00 $66.00 $78.00

Illustrative: segment EBIT × multiple, plus net cash, over basic shares — it does not enter the triangulated fair value.

Peer Quality & Weighting

Peer Fwd P/E Growth Op margin Quality Weight cap
MRSH 15.7× 7% 24% direct 100%
AON 17.1× 7% 36% direct 100%
AJG 16.5× 7% 28% direct 100%
WTW 13.8× 7% 20% direct 100%

Quality-weighted forward P/E: 15.8× (simple median 16.1×). Direct peers count 100%, segment 50%, broad 25%.

Historical-range cross-check: 52-week range $53.81–$96.13, centre $71.90 (+14% vs spot); spot sits at the 21st percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.

Risk / Reward & Margin of Safety

Metric Value
Upside to triangulated FV (FV ÷ price − 1) $56.59 (-10% vs spot · triangulated FV)
Downside to lowest scenario (Structural — Soft-Market / Commission Pressure) $32.30 (-49% vs spot · bear scenario)
Reward-to-risk ratio withheld — the triangulated FV is at or below spot, so there is no reward leg to divide by the risk leg
Discount to fair value (1 − price ÷ FV) -11%
P(price > spot) — Monte Carlo 38%

That ratio is (triangulated FV ÷ price − 1) ÷ (1 − 'Structural — Soft-Market / Commission Pressure' target ÷ price). 'Structural — Soft-Market / Commission Pressure' ($32.30, probability 20%) is the lowest-target scenario in the tree, taken gross of SBC dilution. With a leg missing the ratio is withheld rather than computed from a magnitude. Bull case (Bull — Defensive Re-Rate): $98.40.

04Business & Financial Quality

Company Overview & Business Model

Brown & Brown Inc — FINANCIAL SERVICES · INSURANCE BROKERS. Brown & Brown, Inc. markets and sells insurance products and services in the United States, Bermuda, Canada, the Cayman Islands, Ireland, and the United Kingdom. The company is headquartered in Daytona Beach, Florida.

Company description as supplied by Alpha Vantage; not checked against the company's filings.

How it makes money.

Segment Rev mix Growth Model op margin† Key driver
Insurance Brokerage 100% +7% 30% brokerage organic growth + P&C pricing cycle + bolt-on M&A (fee/commission, no underwriting risk)

† Model margin = gross margin − the opex ratio calibrated so the Monte Carlo median EPS meets the EPS target; it is not a reported operating margin.

Edge. Narrow moat — Insurance broking is capital-light, sticky and high-retention (fee/commission, no underwriting risk) - but the moat is narrow: it rests on local relationships and acquisition sourcing, not a structural barrier, and larger brokers (AON, MMC, WTW) compete for the same accounts. The premium is really an M&A-compounding multiple. Falsifiable: if organic growth normalizes to low-single-digits as the P&C pricing cycle softens and bolt-on multiples rise, the ~13x it trades at is not justified above it and should not re-rate toward the 16x broker peer median.

Revenue-Segment Breakdown

The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)

Segment Revenue Mix Growth Model op margin† Model EBIT Multiple Capex % Tag
Insurance Brokerage $6.3B 100% 7% 30% $1.9B 13.0x 2% ESTIMATE
† Model EBIT = revenue × the model margin, i.e. gross margin less the opex ratio the calibration solved for to meet the EPS target — not the company's reported operating income.

Named Exposures

Demand & pricing cycle (FACT/ESTIMATE)

Dimension Assessment
driver brokerage organic growth + P&C pricing cycle + bolt-on M&A (fee/commission, no underwriting risk)
net_debt_or_cash_b -7.06

Capital intensity & shareholder returns (ESTIMATE)

Dimension Assessment
capex_pct_revenue 0.02
div_yield 0.0102

Structural risk vs optionality (INFERENCE)

Dimension Assessment
downside soft-market / commission pressure
upside specialty / international / consolidation

Balance Sheet & Liquidity

Metric Value
Net debt $6.8B — levered
Net debt / EBITDA 2.36x
Interest coverage (EBIT / interest) 5.6x
Current ratio 1.04x
Lease obligations $0.3B
Cash & ST investments $1.1B

Balance-sheet data as of 2025-12-31 (Alpha Vantage).

Capital Allocation

Metric Value
Free cash flow $1.4B
Buybacks / dividends $0.1B / $0.2B
Total shareholder yield 1.4%
Payout as % of FCF 21.3%
Reinvestment (capex / OCF) 4.7%
SBC as % of FCF 6.7%
Allocation stance reinvesting

Free-Cash-Flow Quality

Metric Value
FCF margin 21.9%
FCF conversion (FCF / net income) 129.5%
FCF yield 6.8%
Capex intensity (capex / revenue) 1.1%
FCF − SBC (diagnostic) $1.3B
Capex split (maint / growth) 75% / 25% — Capital-light broker (~2% capex/rev); PP&E is minimal. The dominant growth spend is acquisition, funded off balance sheet and not in this line. On-P&L capex is largely maintenance IT/office; growth share reflects platform/technology and producer tooling.

Accounting quality: SBC 2% of revenue; cash conversion (OCF/NI) 136% — cash-backed.

Competitive Moat

Moat sources:

  • High client-retention and renewal economics (~90%+) in commercial P&C mid-market
  • Decentralized, incentive-aligned producer culture and local relationships
  • Disciplined bolt-on M&A machine - a process moat, not a structural one
  • No underwriting/balance-sheet risk - capital-light recurring-commission model
05Earnings, Consensus & Catalysts

Earnings-Call Disconfirmation & Sentiment

Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.

Management vs analyst tone (2026Q2): management +0.18 vs analyst floor -0.00 → delta +0.19 (n=39 mgmt / 28 Q&A; 7th pctile across the S&P book, z -1.5).

Flag: CANDID — management unusually candid/cautious vs peers (relatively low spin).

Quarter Mgmt Analyst Delta
2026Q2 +0.18 -0.00 +0.19
2026Q1 +0.25 +0.00 +0.25
2025Q4 +0.24 +0.10 +0.14
2025Q3 +0.38 +0.24 +0.14

News (last 365d, 1383 articles): avg ticker sentiment +0.13 (bullish 19% / bearish 6%)

Consensus & Market Expectations

Reference Value
Street target (mean) $75.06 (+19% vs spot · street)
House target $61.82 (-17.6% vs street)
Sell-side coverage 19 analysts (SB 2 / B 2 / H 14 / S 1 / SS 0; net score 0.13)
Consensus FY EPS $4.48 (reference only — house values on EV/EBITDA)
Consensus FY revenue $7.0B; house below (-4.1%)

_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.

Catalyst Calendar

  • 2026-10-26 (~17d) — Quarterly earnings — est. EPS $1.09 (AV EARNINGS_CALENDAR)
  • 2026-10-27 (~18d) — Investor day / long-term organic-growth and margin framework (authored)
  • 2027-01-15 (~98d) — January 1 P&C commercial renewal pricing read (authored)

Forecast Track Record

  • EPS surprise: beat 75% of the last 8 quarters; average surprise +4.5%.

Catalyst Timeline

6 catalysts in the next 90 days (of 14 tracked). Importance 1–3; confidence 0–1.

When Catalyst Type Importance Confidence
2026-10-14 (in 2d) September CPI macro ●● 0.8
2026-10-26 (in 14d) Quarterly earnings earnings ●●● 0.95
2026-10-27 (in 15d) Investor day / long-term organic-growth and margin framework authored ● 0.7
2026-10-28 (in 16d) FOMC rate decision + press conference macro ●● 0.8
2026-12-09 (in 58d) FOMC rate decision + SEP dot plot macro ●● 0.8
2026-12-18 (in 67d) Quarterly options-expiry cluster (3rd Friday) opex_cluster ● 1.0
2027-01-15 (in 95d) January 1 P&C commercial renewal pricing read authored ● 0.7
2027-01-27 (in 107d) FOMC rate decision + press conference macro ●● 0.8
2027-03-17 (in 156d) FOMC rate decision + SEP dot plot macro ●● 0.8
2027-03-19 (in 158d) Quarterly options-expiry cluster (3rd Friday) opex_cluster ● 1.0
2027-04-28 (in 198d) FOMC rate decision + press conference macro ●● 0.8
2027-06-09 (in 240d) FOMC rate decision + SEP dot plot macro ●● 0.8
2027-06-18 (in 249d) Quarterly options-expiry cluster (3rd Friday) opex_cluster ● 1.0
2027-09-17 (in 340d) Quarterly options-expiry cluster (3rd Friday) opex_cluster ● 1.0

_Sources: extended.catalysts, data/catalysts/.json, data/catalysts/macro.json, AV DIVIDENDS, opex 3rd-Friday calc.

06Risks & Falsification
Issue Probability Valuation sensitivity Horizon
Broker-compensation / contingent-commission disclosure scrutiny low (~20%) low - modest fee-transparency risk; ~2-3% of FV 12-24m
Interest-rate path affecting fiduciary-investment income and deal-financing cost on net debt medium (~40%) medium - float income + leverage cost; ~4-5% of FV 12-24m

Probabilities and sensitivities are analyst estimates, not market-implied.

Scenario Macro & Key Risks

Scenario Macro assumption Key risk
Economic / Exposure Recession Recession shrinks insurable exposure units (payroll, revenue, property values), cutting the commission base. Exposure contraction compounds soft pricing, pushing organic growth negative.
Base — Organic + Pricing + M&A Moderate P&C pricing, mid-single-digit organic growth and a steady bolt-on cadence at disciplined multiples. Leverage near cycle top constrains M&A firepower if credit tightens.
Growth — Specialty / International / Consolidation Firm P&C pricing plus specialty/international expansion and continued industry consolidation. Rising acquisition multiples erode the returns on the M&A engine.
Bull — Defensive Re-Rate Market rewards the recurring, recession-resilient fee model with a defensive re-rate. Re-rate unwinds if the pricing cycle turns and organic growth disappoints.

Scenario-macro rows withheld pending re-authoring: 1 carrying another cluster's vocabulary or a frozen figure — recorded in the narrative quarantine ledger.

Decision Rules (Machine-Checked)

Stance: Hold — 0 bullish / 0 bearish / 0 caution rules triggered of 6 evaluable (0 lacked data).

Rule Condition Observed Triggered
R1-valuation-stretch expected return vs fair value < -12 (upside_pct) -1.68 no
R2-valuation-opportunity expected return vs fair value > 15 (upside_pct) -1.68 no
R3-street-revisions street net rating stance < -0.25 (extended.consensus.street_score) 0.13 no
R4-earnings-quality cash conversion of earnings < 80 (extended.accounting_quality.cash_conversion_pct) 135.9 no
R5-technical-breakdown price vs 200-day SMA < 0.85 (technicals.sma_200) 0.94 no
R6-vol-regime-shift IV/RV vol-risk premium > 1.4 (options_overlay.iv_rv) 1.02 no

Machine-checked rules over disclosed inputs. The authored falsification triggers elsewhere in this report are analyst judgment and are NOT evaluated here. The stance is what the model's own rules read on this name; it does not modify the published research rating, and it is not personal financial advice.

Reasons the Thesis Could Fail (Falsifiable)

Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:

  • Total revenue growth, year-on-year (as reported) < 0.035 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
  • Operating margin, quarterly annualised < 0.286 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
  • US commercial P&C composite renewal rate change (CIAB quarterly survey) < 0.0 (2 consecutive prints). Commission revenue is geared to premium rates. Two consecutive quarters of negative composite renewal pricing marks a broad soft market rather than line-specific softening, and precedes the revenue effect by two to three quarters.
  • Net debt / EBITDA > 3.5 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
  • Diluted EPS, trailing four quarters annualised < 4.57 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)

Fact / Inference / Speculation

  • FACT: Spot $62.88; 52-week range $53.81–$96.13; engine rating HOLD; house target $61.82 (-2%). (source: Alpha Vantage 2026-10-09, 12 October 2026)
  • INFERENCE: Triangulated FV $56.59 (-10% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the DCF anchor sits below the multiple-discipline core.
  • SPECULATION: At current prices the embedded bet is that the market keeps paying the current multiple through the capex cycle — a regime call the engine cannot verify from fundamentals alone.
07Portfolio & Options

Conviction Score

Research Conviction measures the strength and quality of the research setup — input coverage, financial quality, valuation support, process agreement. It is NOT the probability that the recommendation succeeds; the forecast track record section is the evidence on that.

55.3/100 (confidence band 43.5–67.0), 39th percentile of 893 covered names (as of 2026-10-10). Weighted composite under config ros-1.20.0 — every component and its inputs below.

Component Score (0–100) Weight Inputs
business quality 72 15% extended.fcf_quality.fcf_margin_pct, extended.balance_sheet.net_debt_to_ebitda, extended.accounting_quality.cash_conversion_pct
financial strength 40 10% extended.balance_sheet.net_debt_to_ebitda, extended.balance_sheet.interest_coverage
valuation 48 15% upside_pct
growth 56 10% reconciliation.ttm_revenue_billions, reconciliation.fy_guide_revenue_billions
earnings visibility 75 10% extended.forecast_accuracy.eps_surprise.beat_rate_pct
moat 57 10% enrichment.moat.rating
technical trend (heuristic — no validation record; weight change reserved for AM-060) 28 10% technicals.rsi, technicals.sma_50, technicals.sma_200
macro tailwinds — 10% industry_context.house
risk profile 61 10% monte_carlo.prob_above_current, monte_carlo.p10, monte_carlo.p90, monte_carlo.median

Missing inputs (macro tailwinds) are excluded and the remaining weights renormalised; the confidence band widens accordingly.

Score history: 55.0 → 55.1 → 54.9 → 55.1 → 55.1 → 55.3 → 54.9 → 55.3.

Probability-Weighted Return Profile

Horizon: 1 year — at this horizon CAGR equals total return by definition. Expected values are the probability-weighted sums over the full scenario set below.

Scenario Probability Target Total return Contribution
Structural — Soft-Market / Commission Pressure 20% $32.30 -48.6% -9.7pp
Economic / Exposure Recession 17% $52.00 -17.3% -2.9pp
Base — Organic + Pricing + M&A 35% $64.70 +2.9% +1.0pp
Growth — Specialty / International / Consolidation 20% $84.10 +33.7% +6.8pp
Bull — Defensive Re-Rate 8% $98.40 +56.5% +4.5pp
Aggregate Value
Expected return (gross, 1y) -0.4%
Expected return net of SBC dilution -1.9%
Outcome dispersion (σ, from MC p10–p90) 30.9%
Expected Sharpe (rf 4%) -0.14
Downside expectation (prob-weighted loss branches) -12.7%

The gross expected return is the probability-weighted scenario return (it reconciles to the gross PWEV); the diluted figure applies the SBC share-count charge and matches the published PWEV-based target.

Expected Alpha

Expected return minus the return this name is REQUIRED to deliver for its risk (1-year horizon). Constants are pre-registered (preregistered-static (amendment #2, 2026-07-29); not fitted to MCH outcomes).

Component Value
Expected return (gross, 1y) -0.4%
Risk-free rate 4.49% (1y proxy (3m/2y midpoint; AV lacks a 1y tenor), as of 2026-10-08)
Beta (shrunk, 1y vs SPY) 0.13 (as of 2026-10-09)
Equity risk premium 4.5%
Required return 5.1%
Expected alpha -5.5%
Alpha per unit risk (EA/σ) -0.18

A negative expected alpha does not change the rating — it says the expected return does not clear the risk-adjusted hurdle at today's price. Rating mechanics are unchanged by this section.

Probability Cross-Checks

Not authoritative. The scenario probabilities in this report are AUTHORED — a judgement about how the world might go, not a measurement. Nothing below modifies them, the target, the rating or any position size. These checks ask only whether anything outside our own model agrees with us; where it does not, that is information for the reader, not a correction we have quietly applied.

Cross-check Ours Comparator Reading
Scenario spread vs options market 31.8% (1σ) 23.9% implied broadly consistent with the market's implied uncertainty
Mass above spot: scenarios vs our own MC 63.0% 37.9% the scenario weights and the MC parameters disagree about our OWN view — this is a model-coherence issue, not a market disagreement
Realised scenario frequency 58 dated anchors — 58 dated anchors available; realised-vs-prior comparison is now meaningful.

Authored set: 5 scenarios, probabilities summing to 1.0, mean target $62.64.

Flagged for review: internal coherence (authored mass vs Monte Carlo). A flag marks a disagreement worth understanding — it does not imply either side is wrong.

Factor Exposures

Cross-sectional percentiles over 928 covered names (style scores sector-demeaned; thematic = return-beta to the theme's proxy ETF). 50 = estate median.

Style Percentile Theme Percentile
Growth 57 AI 0
Value 32 Cloud 63
Quality 36 Semis 0
Momentum 11 Consumer 17
Low-Vol 25 Rates 15
USD 98
Energy 81

Market interaction: correlation vs SPY +0.15, vs QQQ -0.00 (trailing ~1y daily returns).

08Model Transparency

Rating Bridge

Rating = HOLD because:

  • Probability-weighted scenario value implies -2% vs spot
  • Monte Carlo median implies -10% vs spot
  • DCF fair value (exit-multiple terminal) implies -23% vs spot — but this is terminal-value sensitive (exit-multiple $48.46 vs Gordon $75.61, 56% apart), so it carries less weight
  • Bear case (Structural — Soft-Market / Commission Pressure) downside is -49% vs spot
  • Net: the valuation anchor itself sits 10.0% below spot, so there is no reward leg to weigh against the bear case and the reward-to-risk ratio is withheld rather than computed off a negative upside. The rating is not asymmetric enough for a Buy and not impaired enough for a Sell — hence Hold.

Model Appendix

DCF — line items

Year Revenue Op income (house path) − Capex + D&A FCF PV(FCF)
FY+1 $7B $2B $0B $0B $1B $1B
FY+2 $7B $2B $0B $0B $2B $1B
FY+3 $8B $2B $0B $0B $2B $1B
FY+4 $8B $2B $0B $0B $2B $1B
FY+5 $8B $3B $0B $0B $2B $1B
Terminal — — — — $2B × 12.0x $16B

FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 2% of revenue, weighted from the segments) — not a single conversion fudge.

WACC 8.0% · Σ PV(FCF) $7B + PV(terminal) $16B = EV $23B; − net debt $7.1B → equity $16B ÷ diluted shares $0.32B = $48.46/share (exit-multiple terminal).

  • Gordon terminal → $75.61/share — a single-point perpetual-growth cross-check at g = 2.5% (one growth rate, not a range; it is not in the blend).
  • Incremental ROIC on the forecast capex ≈ 107% vs WACC 8.0% → above WACC — the build is value-creative.

Peer set

Peer EV/Rev Fwd P/E Growth Op margin
MRSH 3.6x 15.7x 7% 24%
AON 4.8x 17.1x 7% 36%
AJG 4.6x 16.5x 7% 28%
WTW 3.0x 13.8x 7% 20%
Median 4.1x 16.1x — —

Implied prices at the peer medians: same-sub-industry median fwd P/E → $72.10; EV/Rev → $57.97.

Weighted fair-value math

Anchor Value Weight Contribution
DCF $48.46 41% $19.95
Scenario PWEV $61.71 29% $18.15
Monte Carlo median $56.67 18% $10.00
Peer P/E $72.10 12% $8.48
Triangulated — 100% $56.59

Assumption Register

Assumption Value Used in Source
WACC 8.0% DCF discount rate estimate (CAPM)
Terminal multiple 12× DCF exit value house rule (0.85 × base multiple)
Terminal growth 2.5% Gordon cross-check (single point) estimate
SBC dilution 1.5%/yr PWEV, MC, DCF (charged once) estimate (from SBC/rev)
EPS basis consensus forward EPS (broker-adjusted, non-GAAP) all forward P/E & scenario multiples definition

Sensitivity-ranked drivers (widest fair-value swing first): Revenue CAGR ±3pp (18.0); Terminal × ±15% (15.0); Model op margin ±3pp (14.0); WACC ±1pp (6.0); Capex intensity ±15% (1.0).

Inputs, Sources & Confidence

Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)

Input Value Type Source Confidence Used in
Revenue TTM $6.3B reported fact 10-K/10-Q via AV High Forecast base, EV/Rev
FY+1 guided revenue $6.7B company guidance Company guidance Medium Forecast, SoP
FY+1 guided EPS $4.4823 company guidance Company guidance Medium Forward P/E, scenarios
Consensus FY EPS $4.4823 consensus estimate Sell-side consensus via AV Medium Variant perception
Diluted shares 0.323B reported fact 10-K via AV High Market cap, per-share
Net debt / cash $6.839B reported fact Balance sheet via AV High EV, DCF equity bridge
WACC 8.0% house estimate CAPM (beta/rf) Medium DCF discount rate
Terminal multiple 12× house estimate House rule: 0.85 × the base multiple (shared with the Monte Carlo) Medium DCF exit value
Terminal growth 2.5% house estimate Long-run GDP+ Medium Gordon cross-check (single point, not in the blend)
SBC dilution 1.5%/yr house estimate From SBC/revenue Medium PWEV, MC, DCF (charged once)

Research Provenance

Field Value
Quantitative engine mch_stock_engine v2.0
Research OS config ros-1.20.0
Analysis as-of 2026-10-12 (prices 2026-10-09)
Narrative authorship claude-opus-5 · Claude Code, supervised, drafted 2026-08-16
Human review Marinus 2026-08-16
Evidence 8/8 load-bearing inputs sourced; 13/14 mandated claims cited
QA scanned post-emit by the document-QA layer; the publication label (Draft / Research / Decision-level) is stamped on the published page, not authored here

Load-Bearing Assumptions

DCF: WACC 8.0%, terminal multiple 12×, FY+5 revenue $8B. Triangulation leans 41% on DCF, 29% on PWEV, 18% on the Monte Carlo median, 12% on peer-implied value.

09Appendix & Audit Trail
Appendix & audit trail — source log, data provenance, disclosures

Source Log

Source Type Date Used for Reference
Alpha Vantage — GLOBAL_QUOTE / OVERVIEW market data 2026-10-09 Price, market cap, EV, forward P/E Alpha Vantage 2026-10-09
MCH engine — trailing 52 weeks of daily bars derived 2026-10-09 52-week range (intraday high and low over the trailing year of the stock's own daily bars) trailing 52 weeks of own daily bars (intraday high/low, 2025-10-10 to 2026-10-09, 251 sessions)
Company income statement (10-K / 10-Q) via Alpha Vantage reported fact 2026-10-09 Revenue, gross/operating margin, EBIT, interest expense INCOME_STATEMENT / latest annual
Company balance sheet (10-K / 10-Q) via Alpha Vantage reported fact 2026-10-09 Cash, debt, net debt, leases, equity, coverage BALANCE_SHEET / latest annual
Company cash-flow statement (10-K / 10-Q) via Alpha Vantage reported fact 2026-10-09 Operating cash flow, capex, FCF, buybacks, dividends, SBC CASH_FLOW / latest annual
Company earnings releases via Alpha Vantage reported fact 2026-10-09 Reported EPS, surprise history EARNINGS / quarterly
Sell-side consensus via Alpha Vantage consensus estimate 2026-10-09 Forward revenue/EPS consensus, analyst count EARNINGS_ESTIMATES
Earnings calendar via Alpha Vantage market data 2026-10-09 Next earnings date, catalyst timing EARNINGS_CALENDAR
Company guidance company guidance 2026-10-09 FY guided revenue / non-GAAP EPS basis company guidance / earnings call
MCH segment model (from filings & disclosures) house estimate 2026-10-09 Segment revenue and multiple; model margin = gross margin − the calibrated opex ratio (not a reported margin) company_context (authored, tagged)
MCH qualitative analysis inference 2026-10-09 Moat, regulatory risk, scenario macro, catalysts company_context enrichment (authored)
MCH investment thesis & falsification triggers house estimate 2026-10-09 Thesis, anti-thesis, thesis-break signals authored §5.3

Citation coverage: 13/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.

Data Sources

  • Prices, fundamentals, options chain, earnings — Alpha Vantage.
  • Company filings (10-K / 10-Q) — SEC filings via EDGAR.

Disclosures & Limitations

This report is for informational and research purposes only. It is not personal financial advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.

  • This report is produced by the MCH Analysis quantitative research engine — valuation, scenarios, Monte Carlo and the decision layer are generated systematically from the disclosed inputs and the archetype/industry driver sets, and reviewed rather than written name-by-name. Every figure reconciles to the appendix and every score exposes its inputs.
  • No suitability assessment has been performed for any individual.
  • Market data may be delayed or inaccurate; figures are as of the analysis date.
  • Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
  • Forecasts are uncertain; past performance is not indicative of future returns.
  • The author or publisher may hold positions in securities mentioned.
  • Users should verify information against primary sources (company filings) before acting.
  • Investing involves risk of loss; there is no guarantee any target price is achieved.
  • Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.

Forecast record. Across 478 scored pre-registered anchors (of 480), the direction implied by our targets has been right 55.2% of the time, above the 50% a coin flip would give, by more than sampling noise at this sample size. Read as probabilities, the targets score worse than a coin flip: a proxy Brier score of 0.253 against 0.25 (lower is better); the probabilities are reconstructed from the price targets, because the engine only began publishing its own on 2026-08-04. By published rating, against each name’s sector ETF (a BUY counts as a hit when it beats it, a SELL when it trails it, a HOLD when it ends within 5 points of it): BUY: 60.0% hits, average alpha +9.6% on 5 scored; HOLD: 31.6%, −1.9% on 418; SELL: 61.4%, −0.5% on 44; STRONG SELL: 33.3%, +0.5% on 6. STRONG BUY: none of its 2 anchors could be scored. Read this page’s price target with that in mind, and see the full accuracy record. Samples are thin and windows short; nothing here is settled in either direction.

General and impersonal investment research. Not personal financial advice. Forecasts, valuations and model outputs are estimates and may be wrong. See Investment Disclaimer.

Disclosures. This report is published by MCH Analysis, a general investment-research publication of MCH Advisory (Pty) Ltd, for informational and quantitative-research purposes only. It is not personal financial advice, legal or tax advice, nor an offer or solicitation to buy or sell any security. Price targets and probabilities are model estimates, not promises; past performance and back-tested or simulated figures do not predict future results. MCH is not a licensed financial services provider or a registered investment adviser; MCH-related persons may hold positions in instruments mentioned (see MCH Interests below).MCH Interests: MCH-related persons and/or associated investment vehicles may hold a financial interest in securities discussed. See Conflicts Policy. Conflicts Policy.Provenance: published 12 October 2026 · Research Standard v4 (decision-level) · Research OS ros-1.20.0 · US-listed · corrections under the Corrections Policy.This report is general research published identically to the relevant readership and is not a recommendation that any transaction is suitable for you. Ratings, fair values and expected returns are estimates as at 9 October 2026 under methodology version ros-1.20.0. MCH Interests: MCH-related persons and/or associated investment vehicles may hold a financial interest in securities discussed. See Conflicts Policy. © 2026 MCH Advisory (Pty) Ltd. Redistribution prohibited.